|
000
| 01625nam##2200301za#4500 |
|---|
| 001 | 9.698387 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210624235914 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150407|1998||||xxc|||||o f|0| 0 eng|d |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aRG79-4/1-1998E-PDF |
|---|
| 110 | 1 |aCanada. |bPatented Medicine Prices Review Board. |
|---|
| 245 | 10|aRoad map for the next decade : |h[electronic resource]|breport on the PMPRB's public consultations |
|---|
| 260 | |aOttawa - Ontario : |bPatented Medicine Prices Review Board |cSeptember 1998. |
|---|
| 300 | |a36p.|btable |
|---|
| 500 | |a"The PMPRB contributes to Canadian health care by ensuring that prices of patented medicines are not excessive."--p.1 of 36. |
|---|
| 520 | 3 |a"The Patented Medicine Prices Review Board (PMPRB) is pleased to report on the results of its consultations regarding the examination of the role, function and methods of the PMPRB. ... It provides a summary of the concerns of stakeholders, and the actions that have been taken to date. It also provides an outline of the measures that we will be taking in order to act on the issues raised by stakeholders."--p.5-6 of 36. |
|---|
| 590 | |a13-20-Supp|b2013-08-30 |
|---|
| 690 | 07|aDrugs|2gcpds |
|---|
| 690 | 07|aPatents|2gcpds |
|---|
| 690 | 07|aPrices|2gcpds |
|---|
| 690 | 07|aGovernment policy|2gcpds |
|---|
| 775 | 08|tLe guide pour la prochaine décennie : |w(CaOODSP)9.642399 |
|---|
| 776 | 0#|tRoad map for the next decade : |w(CaOODSP)9.647224 |
|---|
| 856 | 40|ahttp://publications.gc.ca|qPDF|s124 KB|uhttps://publications.gc.ca/collections/Collection/RG79-4-1-1998E.pdf |
|---|